BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 25442431)

  • 1. Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair.
    Barad L; Schick R; Zeevi-Levin N; Itskovitz-Eldor J; Binah O
    Can J Cardiol; 2014 Nov; 30(11):1279-87. PubMed ID: 25442431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models.
    Kong CW; Akar FG; Li RA
    Thromb Haemost; 2010 Jul; 104(1):30-8. PubMed ID: 20539906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human embryonic stem cell transplantation to repair the infarcted myocardium.
    Leor J; Gerecht S; Cohen S; Miller L; Holbova R; Ziskind A; Shachar M; Feinberg MS; Guetta E; Itskovitz-Eldor J
    Heart; 2007 Oct; 93(10):1278-84. PubMed ID: 17566061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts.
    Caspi O; Huber I; Kehat I; Habib M; Arbel G; Gepstein A; Yankelson L; Aronson D; Beyar R; Gepstein L
    J Am Coll Cardiol; 2007 Nov; 50(19):1884-93. PubMed ID: 17980256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming the promise of pluripotent stem cell-derived cardiomyocytes to a therapy: challenges and solutions for clinical trials.
    Prowse AB; Timmins NE; Yau TM; Li RK; Weisel RD; Keller G; Zandstra PW
    Can J Cardiol; 2014 Nov; 30(11):1335-49. PubMed ID: 25442434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cells in cardiac repair.
    Henning RJ
    Future Cardiol; 2011 Jan; 7(1):99-117. PubMed ID: 21174514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes.
    Bedada FB; Wheelwright M; Metzger JM
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1829-38. PubMed ID: 26578113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myocardial regeneration with cell transplantation therapy].
    Fujita J; Fukuda K
    Nihon Geka Gakkai Zasshi; 2012 Sep; 113(5):441-5. PubMed ID: 23061366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Engraftment of Human Cardiomyocytes Combined with Biodegradable Microparticles Induces Heart Repair.
    Saludas L; Garbayo E; Mazo M; Pelacho B; Abizanda G; Iglesias-Garcia O; Raya A; Prósper F; Blanco-Prieto MJ
    J Pharmacol Exp Ther; 2019 Sep; 370(3):761-771. PubMed ID: 30728248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluripotent stem cell-based heart regeneration: from the developmental and immunological perspectives.
    Lui KO; Bu L; Li RA; Chan CW
    Birth Defects Res C Embryo Today; 2012 Mar; 96(1):98-108. PubMed ID: 22457181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human embryonic stem cell-derived cardiomyocytes for heart therapies.
    Siu CW; Moore JC; Li RA
    Cardiovasc Hematol Disord Drug Targets; 2007 Jun; 7(2):145-52. PubMed ID: 17584049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell sources for cardiac regeneration.
    Roccio M; Goumans MJ; Sluijter JP; Doevendans PA
    Panminerva Med; 2008 Mar; 50(1):19-30. PubMed ID: 18427385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.
    Tachibana A; Santoso MR; Mahmoudi M; Shukla P; Wang L; Bennett M; Goldstone AB; Wang M; Fukushi M; Ebert AD; Woo YJ; Rulifson E; Yang PC
    Circ Res; 2017 Sep; 121(6):e22-e36. PubMed ID: 28743804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration.
    Risueño RM; Sachlos E; Lee JH; Lee JB; Hong SH; Szabo E; Bhatia M
    Stem Cells; 2012 Feb; 30(2):131-9. PubMed ID: 22131151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells.
    Xie X; Sun A; Huang Z; Zhu W; Wang S; Zou Y; Ge J
    Med Hypotheses; 2011 Mar; 76(3):365-7. PubMed ID: 21087827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic stem cell transplantation: promise and progress in the treatment of heart disease.
    Zhang F; Pasumarthi KB
    BioDrugs; 2008; 22(6):361-74. PubMed ID: 18998754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair.
    Dierickx P; Doevendans PA; Geijsen N; van Laake LW
    J Cardiovasc Transl Res; 2012 Oct; 5(5):566-80. PubMed ID: 22806916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrical Stimulation Enhances Cardiac Differentiation of Human Induced Pluripotent Stem Cells for Myocardial Infarction Therapy.
    Ma R; Liang J; Huang W; Guo L; Cai W; Wang L; Paul C; Yang HT; Kim HW; Wang Y
    Antioxid Redox Signal; 2018 Feb; 28(5):371-384. PubMed ID: 27903111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.